The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic and predictive role of HLA supertypes in pMMR mCRC patients receiving FOLFOXIRI/bev ± atezolizumab in the AtezoTRIBE study.
 
Daniele Rossini
Speakers' Bureau - Amgen; Bayer; MSD; Pierre Fabre; Takeda
 
Roberto Moretto
No Relationships to Disclose
 
Francesca Battaglin
No Relationships to Disclose
 
Carlotta Antoniotti
Honoraria - Merck
Travel, Accommodations, Expenses - Merck
 
Federico Scolari
No Relationships to Disclose
 
Francesca Bergamo
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Takeda; Teysuno
Speakers' Bureau - AstraZeneca; Bayer; BMS; Lilly; MSD Oncology
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis
 
Alessandra Russo
No Relationships to Disclose
 
Joshua Millstein
No Relationships to Disclose
 
Ada Taravella
No Relationships to Disclose
 
Stefano Tamberi
Consulting or Advisory Role - AstraZeneca; Seagen; Takeda
Speakers' Bureau - AstraZeneca
 
Veronica Conca
No Relationships to Disclose
 
Ilaria Toma
No Relationships to Disclose
 
Serena Pillozzi
No Relationships to Disclose
 
Paolo Ciracì
No Relationships to Disclose
 
Giovanni Trovato
No Relationships to Disclose
 
Laura Matteucci
No Relationships to Disclose
 
Federica Marmorino
No Relationships to Disclose
 
Lorenzo Antonuzzo
Honoraria - Amgen; AstraZeneca; Novartis; Roche
Consulting or Advisory Role - Merck Serono; MSD Oncology
 
Heinz-Josef Lenz
Honoraria - Abbvie; Adagene; Bayer; Boehringer Ingelheim; Fulgent Genetics; Janssen Oncology; Jazz Pharmaceuticals; Merck Serono; Merus; Roche
Consulting or Advisory Role - 3T BioSciences; Abbvie; Adagene; Bayer; BMS; Fulgent Genetics; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; BMS; Merck Serono
 
Chiara Cremolini
Honoraria - Amgen; Bayer; GlaxoSmithKline; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER; Takeda
Consulting or Advisory Role - Amgen; Bayer; Bicara Therapeutics; MSD; Nordic Bioscience; Pierre Fabre; Revolution Medicines; Roche; Rottapharm Biotech; Takeda
Speakers' Bureau - Merck; MSD; Pierre Fabre; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER